Join these Sponsoring, Exhibiting, and Attending organizations at this premier Life Sciences Industry event
Join these Sponsoring, Exhibiting, and Attending organizations at this premier Life Sciences Industry event
Presentation Opportunities for Research Posters, Early Stage and Clinical Therapeutic Candidates, and Emerging Medical Devices or Health Technologies
SCIENTIFIC POSTERS
ABSTRACTS DUE: Friday, September 1, 2023
The Genomenon team was thrilled with the response to last week’s webinar, Prognosis and Potential: How POLE and PIK3R1 Are Changing How We Approach Endometrial Cancer, with guest speakers from Intermountain Health. The recording is now available to watch, revisit, and share.
Applying Precision Genomics to Optimize Cancer Patient Treatment Recommendations
Clinical biomarkers can be valuable tools for assessing prognosis and treatment options for cancer patients. PIK3R1 and POLE are emerging biomarkers in endometrial cancer. In endometrial cancer patients, PIK3R1 mutations are highly prevalent and associated with poor prognosis, but their biochemical effects in the cell are diverse and not well studied. Conversely, detection of a POLE mutation is associated with good prognosis, which guide clinicians to can spare patients from the toxicity of overtreatment.
Ann Arbor, MI – May 2023 - Genomenon® Mastermind Product Team just released an update based on feedback from our community of users. We are excited to announce two highly requested new features: finding your supplemental match in Professional Edition, and searching the literature by PMID for anyone with a Mastermind account.
MichBio is Your BIO Convention Partner
WHETHER YOU ARE ATTENDING OR NOT, MICHBIO CAN HELP YOU CONNECT
MichBio will be traveling to Boston for the BIO Convention - let us "take you along". Even if you are not planning to attend, sign up and we'll seek out partnering opportunities on your behalf. MichBio can also review your pitch deck, attend meetings with you, and otherwise support your partnering efforts.
The failure of Silicon Valley Bank (SVB) Friday has been a major shock to life sciences companies and the whole ecosystem in Michigan and across the United States. As the second largest bank failure in U.S. history, we know a number of MichBio’s member companies are directly affected by this concerning situation. Since Friday, MichBio has been monitoring the situation and is in contact with state and federal policymakers.
Developing Partnerships Between Michigan's Life Science Industry and the Academic and Educational Professionals Who Supply it with World-Class Talent
A Presentation of the Michigan BioTalent Summit
In Partnership With
